In adults with an ST-elevation myocardial infarct (STEMI), lowered anti-β1-AR Ab levels led to higher rates of re-infarction and cardiovascular death pointing toward a possible protective effect of these antibodies (13). Here, ADRB1 is linked to ST Elevation Myocardial Infarction.